Personal profile
Teaching Experience
Phar 554- Therapeutics IV
Phar 560- Pharmacy Practice Skills Lab
Phar 572- Integrated Studies VI
Phar 580 & 581- Hospital and Inpatient Pharmacy APPE, Providence St. Patrick Hospital
Phar 586- Psychiatric Pharmacy APPE, Providence St. Patrick Hospital
Education/Academic qualification
Doctorate, Pharmacy, University of Montana
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
An international adult guideline for making Clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and Clozapine levels
de Leon, J., Schoretsanitis, G., Smith, R. L., Molden, E., Solismaa, A., Seppälä, N., Kopeček, M., Švancer, P., Olmos, I., Ricciardi, C., Iglesias-Garcia, C., Iglesias-Alonso, A., Spina, E., Ruan, C. J., Wang, C. Y., Wang, G., Tang, Y. L., Lin, S. K., Lane, H. Y. & Kim, Y. S. & 84 others, , Feb 5 2026, In: Chinese Journal of Psychiatry. 59, 2, p. 87-113 27 p.Research output: Contribution to journal › Article › peer-review
-
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I: A Review of the Pharmacokinetic Literature and Proposed Changes
de Leon, J., Baldessarini, R. J., Balon, R., Bilbily, J., Caroff, S. N., Citrome, L., Correll, C. U., Cotes, R. O., Davis, J. M., DeLisi, L. E., Faden, J., Freudenreich, O., Goldsmith, D. R., Gurrera, R., Josiassen, R. C., Kane, J. M., Kelly, D. L., Keshavan, M. S., Laitman, R. S. & Lam, Y. W. F. & 20 others, , May 1 2025, In: Journal of Clinical Psychopharmacology. 45, 3, p. 179-196 18 p.Research output: Contribution to journal › Review article › peer-review
Open Access21 Scopus citations -
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II: A Review of Fatal Outcomes in US Pharmacovigilance Data and Proposed Changes
de Leon, J., Baldessarini, R. J., Balon, R., Bilbily, J., Caroff, S. N., Citrome, L., Correll, C. U., Cotes, R. O., Davis, J. M., DeLisi, L. E., Faden, J., Freudenreich, O., Goldsmith, D. R., Gurrera, R., Josiassen, R. C., Kane, J. M., Kelly, D. L., Keshavan, M. S., Laitman, R. S. & Lam, Y. W. F. & 20 others, , May 1 2025, In: Journal of Clinical Psychopharmacology. 45, 3, p. 197-218 22 p.Research output: Contribution to journal › Review article › peer-review
Open Access20 Scopus citations -
Evaluation of major adverse events of clozapine based on accordance to an international titration guideline
Nuebel, M., Leung, J. G., Hughes, C. & McGrane, I., Jun 1 2024, In: Mental Health Clinician. 14, 3, p. 204-211 8 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Guidance on using Medicaid web portals and other electronic prescriptions claims data to improve admission medication reconciliation in critical access hospitals
Ramsbacher, N. & McGrane, I., Aug 1 2024, In: American Journal of Health-System Pharmacy. 81, 15, p. e392-e393Research output: Contribution to journal › Article › peer-review